Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Vitruvias Therapeutics

Request full access

Vitruvias Therapeutics focuses on developing niche topical generic products that are sold only by prescription

Auburn, United StatesFounded 2013Biotech & Life Sciences

About Vitruvias Therapeutics

Vitruvias Therapeutics is a specialized pharmaceutical company that partners with small global firms to bring international generic products to the U.S. market. The company operates primarily in the generic pharmaceutical sector, focusing on products that are difficult to formulate and manufacture but meet essential healthcare needs. Vitruvias leverages its deep industry expertise and extensive knowledge of U.S. regulatory processes to help its partners successfully navigate the complexities of the American market. The business model revolves around strategic partnerships, long-term relationships, and ethical practices, ensuring that both parties benefit from the collaboration. Vitruvias generates revenue through these partnerships by sharing in the profits from the sale of the generic products in the U.S. market. The company's clients include small to mid-sized pharmaceutical firms looking to expand their market reach into the United States.

Source: Dealroom company data

At a glance

Status
Operational
Employees
6
Open positions
None listed
Dealroom signal
82.9/100
Industry
Health
Sub-industry
Pharmaceutical, BioTechnology
Sector
Biotechnology, Biotech and Pharma, Hard Tech, DT and LS, science-based
Client focus
B2C

Funding history

3 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SERIES A✓Equity / VC Jan 2018 $12M $46M Perceptive Advisors · JW Asset Management —
SEED✓Equity / VC Aug 2014 $200K $800K Undisclosed —
Showing the latest 2 of 3 recorded eventsBook a demo for the full funding history →

Growth signals

Vitruvias Therapeutics website traffic

Latest recorded traffic for Vitruvias Therapeutics is 1.7K monthly website visits, up 54.5% over the last three months. Vitruvias Therapeutics's team grew 50% over the past year.

Latest monthly visits1.7K 3-month web change+54.5% 1-year team growth+50%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

CompanyHeadquartersStatusEmployeesTotal fundingValuation
aperio beautyPersonalized Anti-Aging Solution Based on Your Unique DNA We investigate the genetics behind skin health and aging – guiding our careful selection… Los Angeles, United States Operational 4 $1.3M —
Curex AllergyAllergy relief made convenient. Custom treatments to desensitize your body to your allergies New York City, United States Operational
Vero BiotechAn emerging biotechnology company focused on the design, development, and commercialization of next generation inhaled nitric oxide (NO) delivery systems to address unmet medical needs of patients with cardiopulmonary conditions Atlanta, United States Operational
Memory-Lane.tvPersonalized video platform enhancing dementia care through multi-sensory therapies and reducing psychoactive medication use Portland, United States Operational
Base4Microdroplet-based single molecule DNA sequencing technology. Cambridge, United Kingdom Operational
OxagenSmall molecule drugs for inflammatory and respiratory diseases Milton, United Kingdom Operational
ChronicledChronicled is a technology company leveraging blockchain and IoT to power smart, secure supply chain solutions San Francisco, United States Operational
NuvOx PharmaNuvOx Pharma is a biotechnology company based in Tucson, Arizona that is developing a first-in-class oxygen therapeutic to treat life-threatening diseases where hypoxia plays a role Tucson, United States Operational
Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Vitruvias Therapeutics in the Auburn ecosystem

Live from Dealroom

The Vitruvias Therapeutics office with the hot startups, most funded companies and investors around it. Hover or tap a pin.

Loading the map…

Dealroom maps whole ecosystems like this one for cities, regions and governments. See the ecosystem platform →

Investors

2 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Series A2 investors entered at this stage

Team profiled 3 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 3 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
1 countries with
team presence
🇺🇸 United States100%
1 country shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Vitruvias Therapeutics on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Vitruvias Therapeutics’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.